July 26, 2018Open Access

Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden

Key Points

Key points are not available for this paper at this time.

Abstract

We need to apply novel findings towards sustainable approaches for treating and preventing Shigella infections. Vaccines and alternative treatments are under development and may offer an opportunity to reduce the burden of Shigella disease and restrict the mobility of antimicrobial resistant clones.

Bookmark

View Full Paper

Cite This Study

Baker et al. (Thu,) studied this question.

synapsesocial.com/papers/69d9534e16f0d2beeba3c5e3 https://doi.org/https://doi.org/10.1097/qco.0000000000000475

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization2002 · 119 citations
2<i>Shigella</i> from Humans in Thailand During 1993 to 2006: Spatial-Time Trends in Species and Serotype Distribution2008 · 42 citations
3A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility2016 · 2,839 citations
4The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study2012 · 385 citations
5Assessing gut microbiota perturbations during the early phase of infectious diarrhea in Vietnamese children2017 · 79 citations

Bookmark

View Full Paper